Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
VRDN
Viridian Therapeutics, Inc.\De
CALL
$1.69 Million
74.3K
Q3 2024
Added 54.25%
DYN
Dyne Therapeutics, Inc.
PUT
$1.68 Million
46.9K
Q3 2024
Added 28.79%
ARQT
Arcutis Biotherapeutics, Inc.
CALL
$1.67 Million
180K
Q3 2024
Reduced 8.04%
RNA
Avidity Biosciences, Inc.
PUT
$1.67 Million
36.3K
Q3 2024
Reduced 1.56%
IMVT
Immunovant, Inc.
CALL
$1.62 Million
58.9K
Q3 2024
Added 60.49%
GERN
Geron Corp
PUT
$1.5 Million
331K
Q3 2024
Added 23.2%
HUMA
Humacyte, Inc.
PUT
$1.5 Million
275K
Q3 2024
Added 4603.74%
ANVS
Annovis Bio, Inc.
CALL
$1.49 Million
185K
Q3 2024
New holding
GLPG
Galapagos Nv
CALL
$1.48 Million
51.5K
Q2 2024
Added 272.31%
TECH
Bio Techne Corp
CALL
$1.45 Million
18.2K
Q3 2024
Reduced 18.25%
ABUS
Arbutus Biopharma Corp
CALL
$1.43 Million
372K
Q3 2024
Reduced 81.49%
SANA
Sana Biotechnology, Inc.
CALL
$1.43 Million
343K
Q3 2024
Added 107.64%
TERN
Terns Pharmaceuticals, Inc.
PUT
$1.42 Million
170K
Q3 2024
Added 28.04%
KROS
Keros Therapeutics, Inc.
CALL
$1.42 Million
24.4K
Q3 2024
Added 7.95%
NRIX
Nurix Therapeutics, Inc.
CALL
$1.39 Million
61.7K
Q3 2024
Reduced 64.2%
ACAD
Acadia Pharmaceuticals Inc
PUT
$1.36 Million
88.1K
Q3 2024
Added 104.55%
LGND
Ligand Pharmaceuticals Inc
CALL
$1.35 Million
13.5K
Q3 2024
Added 44.95%
RCUS
Arcus Biosciences, Inc.
PUT
$1.31 Million
85.8K
Q3 2024
Reduced 51.41%
CRNX
Crinetics Pharmaceuticals, Inc.
PUT
$1.28 Million
25K
Q3 2024
Added 38.92%
LEGN
Legend Biotech Corp
CALL
$1.27 Million
26K
Q3 2024
Reduced 9.55%
BCRX
Biocryst Pharmaceuticals Inc
CALL
$1.26 Million
166K
Q3 2024
Reduced 15.01%
HRMY
Harmony Biosciences Holdings, Inc.
PUT
$1.25 Million
31.4K
Q2 2024
New holding
MRVI
Maravai Lifesciences Holdings, Inc.
CALL
$1.23 Million
148K
Q3 2024
Reduced 87.86%
EYPT
Eye Point Pharmaceuticals, Inc.
PUT
$1.19 Million
149K
Q3 2024
Reduced 79.13%
SAGE
Sage Therapeutics, Inc.
CALL
$1.17 Million
162K
Q3 2024
Reduced 49.98%
INMB
Inmune Bio, Inc.
CALL
$1.15 Million
213K
Q2 2024
Reduced 72.38%
AVXL
Anavex Life Sciences Corp.
CALL
$1.1 Million
194K
Q3 2024
Reduced 9.84%
SRRK
Scholar Rock Holding Corp
CALL
$1.08 Million
135K
Q3 2024
Reduced 1.15%
ITOS
I Teos Therapeutics, Inc.
CALL
$1.08 Million
106K
Q3 2024
Reduced 82.09%
TVTX
Travere Therapeutics, Inc.
CALL
$1.07 Million
76.8K
Q3 2024
Reduced 63.44%
AVXL
Anavex Life Sciences Corp.
PUT
$1.07 Million
189K
Q3 2024
Reduced 9.84%
CCCC
C4 Therapeutics, Inc.
CALL
$1.07 Million
188K
Q3 2024
Added 13.8%
PTGX
Protagonist Therapeutics, Inc
CALL
$1.07 Million
23.8K
Q3 2024
Reduced 88.65%
FDMT
4 D Molecular Therapeutics, Inc.
CALL
$1.07 Million
98.8K
Q3 2024
Reduced 27.19%
ANVS
Annovis Bio, Inc.
PUT
$1.05 Million
131K
Q3 2024
New holding
AMLX
Amylyx Pharmaceuticals, Inc.
PUT
$1.03 Million
318K
Q3 2024
Reduced 8.94%
KMPH
Kempharm, Inc
PUT
$980,000
199K
Q3 2024
Added 55.08%
NRIX
Nurix Therapeutics, Inc.
PUT
$974,000
43.4K
Q3 2024
Reduced 64.2%
KYMR
Kymera Therapeutics, Inc.
CALL
$970,000
20.5K
Q3 2024
Added 33.28%
IDYA
Ideaya Biosciences, Inc.
CALL
$950,000
30K
Q3 2024
Added 18.61%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$948,000
49K
Q3 2024
Added 179.2%
MLTX
Moon Lake Immunotherapeutics
CALL
$932,000
18.5K
Q2 2024
Reduced 76.56%
PRTA
Prothena Corp Public LTD CO
PUT
$923,000
55.2K
Q3 2024
Added 40.38%
ZLAB
Zai Lab LTD
CALL
$914,000
37.9K
Q2 2024
Reduced 11.21%
VCEL
Vericel Corp
CALL
$912,000
21.6K
Q3 2024
Added 47.97%
TARS
Tarsus Pharmaceuticals, Inc.
CALL
$907,000
27.6K
Q3 2024
New holding
GLPG
Galapagos Nv
PUT
$895,000
31.1K
Q2 2024
Added 272.31%
VCYT
Veracyte, Inc.
CALL
$884,000
26K
Q3 2024
Reduced 76.84%
ADMA
Adma Biologics, Inc.
PUT
$865,000
43.3K
Q3 2024
Reduced 20.55%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email